Promising hematologists begin year-long program to pursue careers in clinical hematology research

July 02, 2008

(WASHINGTON, July 2, 2008) - Twenty hematology and hematology/oncology fellows and junior faculty will begin a unique year-long education and mentoring program this summer as part of the American Society of Hematology (ASH) Clinical Research Training Institute.

Each year, the Clinical Research Training Institute provides aspiring hematologists with the necessary tools to begin careers in clinical research. The program, which is now in its sixth year, begins with a week-long summer workshop that focuses on the fundamentals of research. Participants also have the opportunity to work on their own proposed clinical research projects with interaction from expert faculty. Two subsequent sessions, one at the ASH annual meeting in December and one the following spring, provide further mentoring opportunities.

"As the need for clinical researchers in hematology continues to grow, it's extremely important to provide fellows and junior faculty with opportunities to develop their research skills," said ASH President Kenneth Kaushansky, MD, of the University of California - San Diego School of Medicine. "Several past participants have described their experience with this program as one of the greatest career development opportunities they have had."

The 2008 Clinical Research Training Institute participants are:

Dale Bixby, MD, PhD, University of Michigan
Beth Christian, MD, The Ohio State University
James Cooper, MD, Children's Hospital of Pittsburgh, University of Pittsburgh
Adam Cuker, MD, University of Pennsylvania
Jennifer Cultrera, MD, The University of Texas M. D. Anderson Cancer Center
Michelle Heather Gilbert, MD, University of Utah School of Medicine
Shannon Jackson, MD, University of Calgary
Emma Jones, MD, Baylor College of Medicine, Texas Children's Hospital
Patricia Kropf, MD, University of Pittsburgh Cancer Institute
Tomer Mark, MD, Weill Cornell Medical College
Timothy McCavit, MD, University of Texas Southwestern Medical Center
Ara Metjian, MD, Duke University
Daniel Pollyea, MD, Stanford University
Anita Rajasekhar, MD, University of Florida College of Medicine
Lori Rosenstein, MD, University of Iowa Hospitals and Clinics
Rafael Santana-Davila, MD, Mayo Clinic
William Savage, MD, Johns Hopkins University School of Medicine
Rajni Sinha, MD, MRCP, Emory University
Monica Thakar, MD, Fred Hutchinson Cancer Research Center
Ronald Walter, MD, PhD, Fred Hutchinson Cancer Research Center

This program is offered to hematology and hematology/oncology fellows as well as junior faculty who are within three years of completing their fellowship training at academic medical centers in the United States and Canada. For more information, please visit www.hematology.org/education/training/crti.cfm.
-end-
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

American Society of Hematology

Related Clinical Research Articles from Brightsurf:

Day after COVID-19: Time to rethink oncology clinical research
This Viewpoint discusses how the COVID-19 pandemic may reshape clinical practice and clinical research as new technologies are incorporated and old practices are revisited and revamped.

Pregnant and lactating women with COVID-19: Scant clinical research
Pregnant and breastfeeding women have been excluded from clinical trials of drugs to treat COVID-19, and as result, there is no safety data to inform clinical decisions.

Serum irisin: Pathogenesis and clinical research in cardiovascular diseases
In a new publication from Cardiovascular Innovations and Applications; Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.

People fearful of taking part in vital clinical research
A review, led by researchers at the University of York and Hull York Medical School, has found that fear about testing new treatments and possible side effects was the most common reason given by patients for not wanting to participate.

Clinical research improves health of UK economy and NHS
The value of clinical research to the NHS, the UK economy and jobs market has been evaluated in a new report, which provides an assessment of the economic impact of the National Institute for Health Research Clinical Research Network's (NIHR CRN) activities to support clinical research in England.

Research discovery leads to new clinical trial for myelofibrosis patients
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

New research: Financial disclosure lacking in publication of clinical trials
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows.

How to ethically conduct clinical research during public health emergencies
Carnegie Mellon University's Alex John London, a prominent bioethicist, has co-authored a viewpoint article in PLOS: Neglected Tropical Diseases on the ethics of clinical research during public health emergencies, like Ebola outbreaks.

Early results from clinical trials not all they're cracked up to be, shows new research
When people are suffering from a chronic medical condition, they may place their hope on treatments in clinical trials that show early positive results.

Collection provides tools to improve clinical research in Africa and Asia
Quality assurance of clinical research is critical to ensure meaningful results in compliance with universal ethical standards.

Read More: Clinical Research News and Clinical Research Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.